Extended Data Fig. 2: Characteristics of representative antibodies against pseudotyped viruses.
From: Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants

a, Heatmap representation of five therapeutic mAbs approved or in clinical trials against pseudotyped viruses with the S proteins of wild-type or variants of concern or interst (Alpha, Beta, Gamma, Delta, Lambda and Omicron). b, Neutralization curves for these mAbs in correspondence with a. Mean of two experiments is shown.